Board/Management Information • Jun 15, 2020
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 8893P
Indivior PLC
15 June 2020
June 15, 2020
Indivior PLC - Board Announcement
Chair to take a leave of absence
Indivior PLC announces that the Chair, Howard Pien, is to take a leave of absence for medical reasons. Daniel Tassé will act as Interim Chair in Mr Pien's absence.
Daniel joined the Board in 2014 and was appointed Senior Independent Director in 2016 (bio). He is a member of the Audit and Remuneration Committees and is also a member of the Special Committee.
In considering Mr Tassé's appointment as Interim Chair, the Board took into account his deep understanding of the pharmaceuticals sector and Indivior's business and his confirmation that he is able to devote sufficient time to the role.
Investor Contact:
Jason Thompson, Indivior
Vice President, Investor Relations
+1 804-402-7123
Media Contacts:
UK
Tulchan Communications
+44 207-353-4200
US
+1 804-594-0836
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BOADGGDLXBBDGGS
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.